Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 53 (4) , 889-897
- https://doi.org/10.1016/s0360-3016(02)02824-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Breast carcinomas of limited extentCancer, 2001
- 5-year results of a prospective phase II trial of wide-volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0–1 breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Factors Determining Outcome for Breast-Conserving Irradiation with Margin-Directed Dose Escalation to the Tumor BedInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: Preliminary results of a pilot trialInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Long-term outcome following breast-conserving surgery and radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Dose uniformity in a planar interstitial implant systemInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Pathologic findings from the national surgical adjuvant breast project (protocol 6). Relation of local breast recurrence to multicentricityCancer, 1986
- Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast-conserving surgeryCancer, 1985
- Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapyCancer, 1984
- “Residual” mammary carcinoma following simulated partial mastectomyCancer, 1975